Scholar Rock Holding (SRRK) Other Non Operating Income (2017 - 2026)
Scholar Rock Holding's (SRRK) quarterly Other Non Operating Income came in at -$3.3 million in Q1 2026, down 7484.09% year-on-year from $45191.8 in Q1 2025, and down 5370.49% quarter-over-quarter from -$61000.0 in Q4 2025.
Scholar Rock Holding (SRRK) Other Non Operating Income (2017 - 2026) Analysis & Trends
Scholar Rock Holding's Other Non Operating Income history runs 5 years deep, the most recent figure standing at -$3.3 million for Q1 2026.
- On a quarterly basis, Other Non Operating Income fell 7484.09% year-over-year to -$3.3 million in Q1 2026; TTM through Mar 2026 was -$3.6 million, a 3227.78% decrease from a year earlier, with the FY2025 full-year figure at -$301000.0, down 254.12% from the prior year.
- Other Non Operating Income declined to -$3.3 million in Q1 2026 per SRRK's latest filing, from -$61000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $21000.0 in Q1 2024 and bottomed at -$3.3 million in Q1 2026.
- The 3-year median for Other Non Operating Income is -$44000.0 (2025), against an average of -$409000.0.
- Across the five-year window, Other Non Operating Income sank 81.58% in 2025 and sank 7484.09% in 2026, its largest moves.
- Year by year, Other Non Operating Income stood at -$12000.0 in 2024, then plunged by 408.33% to -$61000.0 in 2025, then sank by 5370.49% to -$3.3 million in 2026.
- Per Business Quant, the three latest SRRK Other Non Operating Income figures stand at -$3.3 million (Q1 2026), -$61000.0 (Q4 2025), and -$69000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Scholar Rock Holding | 6.30 Bn | 6.30 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.34 Mn |
| Dec 31, 2025 | -61,000.00 |
| Sep 30, 2025 | -69,000.00 |
| Jun 30, 2025 | -127,000.00 |
| Mar 31, 2025 | -44,000.00 |
| Dec 31, 2024 | -12,000.00 |
| Sep 30, 2024 | -38,000.00 |
| Jun 30, 2024 | -14,000.00 |
| Mar 31, 2024 | 21,000.00 |
| Jun 30, 2018 | -36,000.00 |
| Mar 31, 2018 | -20,000.00 |
| Dec 31, 2017 | -11,000.00 |
| Sep 30, 2017 | 4,000.00 |
| Jun 30, 2017 | -2,000.00 |